2013
DOI: 10.1021/ml4002562
|View full text |Cite
|
Sign up to set email alerts
|

Exploring the Chemical Space of Multitarget Ligands Using Aligned Self-Organizing Maps

Abstract: Design of multitarget drugs and polypharmacological compounds has become popular during the past decade. However, the main approach to design such compounds is to link two selective ligands via a flexible linker. Although such chimeric ligands often have reasonable potency in vitro, the in vivo efficacy is low due to high molecular weight, low ligand efficiency, and poor pharmacokinetic profile. We developed an unprecedented in silico approach for fragment-based design of multitarget ligands. It relies on supe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
22
0
1

Year Published

2015
2015
2021
2021

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 35 publications
(23 citation statements)
references
References 28 publications
0
22
0
1
Order By: Relevance
“…Based on the chemical knowledge of the ligands and/or their targets, it is possible to design molecules from combining different pharmacophores able to reach different sites of the same protein or distinct proteins (bi-target or multi-target compounds), which could improve the anti-proliferative effect in situ, and consequently, in the improvement of the treatment efficiency 36 .…”
Section: Docking Simulations Of Vpa Aryl Derivatives On Hdac8mentioning
confidence: 99%
“…Based on the chemical knowledge of the ligands and/or their targets, it is possible to design molecules from combining different pharmacophores able to reach different sites of the same protein or distinct proteins (bi-target or multi-target compounds), which could improve the anti-proliferative effect in situ, and consequently, in the improvement of the treatment efficiency 36 .…”
Section: Docking Simulations Of Vpa Aryl Derivatives On Hdac8mentioning
confidence: 99%
“…After the closing phase of this project, 2‐phenylbenzimidazole and related derivatives were reported as fragment hits for sEH on the basis of elaborate in silico approaches . Whereas the best 2‐phenylbenzimidazole compound from those in silico screenings has a potency in the low micromolar range, compound 16 as a representative of our 2‐phenylbenzimidazole‐4‐sulfonamides has significantly higher potency (IC 50 =17 n m ).…”
Section: Resultsmentioning
confidence: 99%
“…After the closing phase of this project, 2-phenylbenzimidazole and relatedd erivatives were reported as fragment hits for sEH on the basis of elaborate in silico approaches. [27,43] Whereas the best 2-phenylbenzimidazole compound from those in silico screenings has ap otency in the low micromolar range, compound 16 as ar epresentative of our 2-phenylbenzimidazole-4sulfonamides has significantly higher potency( IC 50 = 17 nm). More importantly,t he induced-fit features associated with the 2-phenylbenzimidazole-4-sulfonamide scaffolda sr evealed by high-resolution crystal structures present distinct novel interactions with sEH.…”
Section: -Phenylbenzimidazole-4-sulfonamide Was Identified As Ah It mentioning
confidence: 98%
See 2 more Smart Citations